Skip to main content
. 2024 Nov 20;29:555. doi: 10.1186/s40001-024-02150-6

Table 2.

Relapsed patients in the control group and the prednisone increment group

Endpoint Control group (n = 95) Prednisone increment group (n = 58) P value
Recurrence (n, %) 24 (25.3) 3 (5.2) 0.002
Renal recurrence (n, %) 13 (13.7) 1 (1.7) 0.013
Extrarenal recurrence (n, %) 11 (11.6) 2 (3.4) 0.080